slotkoers
Korea S.E.
00:00:00 24-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
5.230
KRW
|
-3,68%
|
|
-7,10%
|
-14,26%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
1.575.578
|
918.379
|
1.924.170
|
883.065
|
598.978
|
417.573
|
Bedrijfswaarde
1 |
1.475.178
|
882.872
|
1.856.126
|
800.346
|
514.392
|
345.733
|
K/w-verhouding
|
10,7
x
|
-126
x
|
-268
x
|
-963
x
|
-242
x
|
-13,3
x
|
Dividendrendement
|
0,81%
|
1,33%
|
0,32%
|
0,78%
|
-
|
-
|
Marktkapitalisatie/omzet
|
8,11
x
|
5,46
x
|
11,3
x
|
4,84
x
|
3,14
x
|
3,32
x
|
Bedrijfswaarde/omzet
|
7,6
x
|
5,25
x
|
10,9
x
|
4,39
x
|
2,69
x
|
2,75
x
|
Bedrijfswaarde/EBITDA
|
35,1
x
|
57,4
x
|
182
x
|
76,5
x
|
105
x
|
-10,4
x
|
Bedrijfswaarde/FCF
|
64
x
|
-37,5
x
|
1.410
x
|
31,7
x
|
55,4
x
|
5,85
x
|
FCF Yield
|
1,56%
|
-2,67%
|
0,07%
|
3,15%
|
1,81%
|
17,1%
|
Price to Book
|
2,93
x
|
2,81
x
|
7,44
x
|
3,28
x
|
2,28
x
|
1,85
x
|
Aantal aandelen (in duizenden)
|
73.379
|
70.398
|
68.476
|
68.455
|
68.455
|
68.455
|
Referentieprijs
2 |
21.472
|
13.045
|
28.100
|
12.900
|
8.750
|
6.100
|
Datum van publicatie
|
7/03/19
|
5/03/20
|
11/03/21
|
17/03/22
|
20/03/23
|
14/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
194.224
|
168.194
|
169.660
|
182.491
|
190.909
|
125.928
|
EBITDA
1 |
42.003
|
15.377
|
10.186
|
10.465
|
4.886
|
-33.204
|
Bedrijfsresultaat (EBIT)
1 |
35.127
|
9.537
|
4.028
|
5.622
|
-230,6
|
-37.497
|
Operationele Marge
|
18,09%
|
5,67%
|
2,37%
|
3,08%
|
-0,12%
|
-29,78%
|
Resultaat voor belastingen (EBT)
1 |
191.056
|
-1.362
|
-8.300
|
3.787
|
-1.033
|
-39.569
|
Nettowinst (verlies)
1 |
145.670
|
-7.412
|
-7.203
|
-916,6
|
-2.475
|
-31.330
|
Nettomarge
|
75%
|
-4,41%
|
-4,25%
|
-0,5%
|
-1,3%
|
-24,88%
|
WPA
2 |
2.011
|
-103,3
|
-105,0
|
-13,39
|
-36,15
|
-458,0
|
Free Cash Flow
1 |
23.038
|
-23.535
|
1.316
|
25.241
|
9.285
|
59.149
|
FCF-marge
|
11,86%
|
-13,99%
|
0,78%
|
13,83%
|
4,86%
|
46,97%
|
Kasstroomconversie (ebitda)
|
54,85%
|
-
|
12,92%
|
241,21%
|
190,04%
|
-
|
Kasstroomconversie (nettowinst)
|
15,82%
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
2 |
173,2
|
173,2
|
90,91
|
100,0
|
-
|
-
|
Datum van publicatie
|
7/03/19
|
5/03/20
|
11/03/21
|
17/03/22
|
20/03/23
|
14/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
100.400
|
35.507
|
68.044
|
82.719
|
84.586
|
71.840
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
23.038
|
-23.535
|
1.316
|
25.241
|
9.285
|
59.149
|
ROE (netto-inkomsten/eigen vermogen)
|
46,6%
|
-2,01%
|
-3,38%
|
-1,01%
|
-1,54%
|
-13,6%
|
ROA (netto-inkomsten/totale activa)
|
6,02%
|
1,35%
|
0,64%
|
0,88%
|
-0,04%
|
-5,65%
|
Totale activa
1 |
2.421.337
|
-548.495
|
-1.129.529
|
-104.150
|
6.855.550
|
554.763
|
Nettoactief per aandeel
2 |
7.324
|
4.634
|
3.775
|
3.938
|
3.845
|
3.306
|
Cashflow per aandeel
2 |
1.779
|
534,0
|
1.158
|
1.209
|
1.249
|
2.209
|
Capex
1 |
3.708
|
3.538
|
1.917
|
785
|
4.298
|
2.835
|
Capex/omzet
|
1,91%
|
2,1%
|
1,13%
|
0,43%
|
2,25%
|
2,25%
|
Datum van publicatie
|
7/03/19
|
5/03/20
|
11/03/21
|
17/03/22
|
20/03/23
|
14/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -14,26% | 258 mln. | | +18,96% | 42,97 mld. | | +24,56% | 22,16 mld. | | +20,30% | 14,56 mld. | | +54,98% | 13,03 mld. | | -0,05% | 6,79 mld. | | -11,35% | 6,46 mld. | | +17,73% | 5,87 mld. | | -8,87% | 5,73 mld. | | +6,11% | 4,61 mld. |
Generieke geneesmiddelen
|